The American Journal of Managed Care

BIM-IOL Lowers IOP 35%, Ends Drops for Most Patients: Fiaz Zaman, MD

The Bimatoprost Drug Pad-IOL (BIM-IOL) System, developed by SpyGlass Pharma, uses 2 drug-eluting pads attached to the lens to ...
The American Journal of Managed Care

A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD

In the pivotal BRUNELLO trial, both doses of remigromig, a Wnt pathway agonist, were noninferior to ranibizumab for diabetic ...
The American Journal of Managed Care

Big Data, MIGS Are Crucial Areas of Glaucoma Treatment: AAO Panel

A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help ...
The American Journal of Managed Care

Using Complement Inhibitors in GA Comes With Pros and Cons

A vote taken by the sound of applause rang out during an early morning session at (AAO) 2026 annual meeting, where 2 experts discussed the pros and cons of using complement inhibitors to treat ...
The American Journal of Managed Care

Population Health, Equity & Outcomes

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...